Literature DB >> 24360390

Health technology assessment in universal health coverage.

Kalipso Chalkidou1, Robert Marten2, Derek Cutler3, Tony Culyer4, Richard Smith5, Yot Teerawattananon6, Francoise Cluzeau3, Ryan Li3, Richard Sullivan7, Yanzhong Huang8, Victoria Fan9, Amanda Glassman9, Yu Dezhi10, Martha Gyansa-Lutterodt11, Sam McPherson12, Carlos Gadelha13, Thiagarajan Sundararaman14, Neil Squires15, Nils Daulaire16, Rajeev Sadanandan17, Konuma Shiro18, Alexandre Lemgruber19.   

Abstract

Mesh：

Year:  2013        PMID： 24360390     DOI： 10.1016/S0140-6736(13)62559-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

Review 1.  Economic evaluation of HBV vaccination: A systematic review of recent publications (2000-2013).

Authors:  Giuseppe La Torre; Alice Mannocci; Rosella Saulle; Vittoria Colamesta; Angela Meggiolaro; Daniele Mipatrini; Alessandra Sinopoli
Journal:  Hum Vaccin Immunother       Date:  2016-04-22       Impact factor: 3.452

2.  A systematic review of health technology assessment tools in sub-Saharan Africa: methodological issues and implications.

Authors:  Christine Kriza; Jill Hanass-Hancock; Emmanuel Ankrah Odame; Nicola Deghaye; Rashid Aman; Philip Wahlster; Mayra Marin; Nicodemus Gebe; Willis Akhwale; Isabelle Wachsmuth; Peter L Kolominsky-Rabas
Journal:  Health Res Policy Syst       Date:  2014-12-02

3.  Exchanging and using research evidence in health policy networks: a statistical network analysis.

Authors:  Jessica C Shearer; Michelle Dion; John N Lavis
Journal:  Implement Sci       Date:  2014-10-30       Impact factor: 7.327

Review 4.  Methods for medical device and equipment procurement and prioritization within low- and middle-income countries: findings of a systematic literature review.

Authors:  Karin Diaconu; Yen-Fu Chen; Carole Cummins; Gabriela Jimenez Moyao; Semira Manaseki-Holland; Richard Lilford
Journal:  Global Health       Date:  2017-08-18       Impact factor: 4.185

5.  Health Technology Assessment: Global Advocacy and Local Realities Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness".

Authors:  Kalipso Chalkidou; Ryan Li; Anthony J Culyer; Amanda Glassman; Karen J Hofman; Yot Teerawattananon
Journal:  Int J Health Policy Manag       Date:  2017-04-01

6.  Comprehensive taxonomy and worldwide trends in pharmaceutical policies in relation to country income status.

Authors:  N Maniadakis; G Kourlaba; J Shen; A Holtorf
Journal:  BMC Health Serv Res       Date:  2017-05-25       Impact factor: 2.655

7.  Disease Control Priorities Third Edition Is Published: A Theory of Change Is Needed for Translating Evidence to Health Policy.

Authors:  Ole F Norheim
Journal:  Int J Health Policy Manag       Date:  2018-09-01

8.  Use of medicine pricing and reimbursement policies for universal health coverage in Indonesia.

Authors:  Riswandy Wasir; Sylvi Irawati; Amr Makady; Maarten Postma; Wim Goettsch; Erik Buskens; Talitha Feenstra
Journal:  PLoS One       Date:  2019-02-19       Impact factor: 3.240

9.  Implementation and Operational Research: Programmatic Feasibility of Dried Blood Spots for the Virological Follow-up of Patients on Antiretroviral Treatment in Nord Kivu, Democratic Republic of the Congo.

Authors:  François Boillot; Laetitia Serrano; Jeremie Muwonga; Jean Pierre Kabuayi; Alain Kambale; Fidèle Mutaka; Paula I Fujiwara; Josef Decosas; Martine Peeters; Eric Delaporte
Journal:  J Acquir Immune Defic Syndr       Date:  2016-01-01       Impact factor: 3.731

Review 10.  Incorporating MCDA into HTA: challenges and potential solutions, with a focus on lower income settings.

Authors:  Kevin Marsh; Praveen Thokala; Sitaporn Youngkong; Kalipso Chalkidou
Journal:  Cost Eff Resour Alloc       Date:  2018-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.